XML 26 R14.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Stock Based Compensation
12 Months Ended
Dec. 31, 2019
Share-based Payment Arrangement [Abstract]  
Stock Based Compensation Stock Based Compensation
The Company accounts for stock-based compensation pursuant to relevant authoritative guidance, which requires measurement of compensation cost for all stock awards at fair value on the date of grant and recognition of compensation, net of estimated forfeitures, over the requisite service period for awards expected to vest. The Company has Stock Incentive Plans (the Plans) pursuant to which the Company’s board of directors may grant stock options or restricted stock to employees. The Company is authorized to issue grants of restricted stock and stock options to purchase up to 30,463,150 shares for the years ended December 31, 2019 and 2018, respectively, and 26,963,150 shares for the year ended December 31, 2017.
On February 7, 2018, the stockholders of the Company approved the FLEETCOR Technologies, Inc. Amended and Restated 2010 Equity Incentive Plan (the "Amended Plan"). The Amended Plan was authorized and approved by the Company's Board of Directors on December 20, 2017, and Company's stockholders at a special meeting held on February 7, 2018. The Amended Plan amends the Registrant’s existing 2010 Equity Incentive Plan (as amended, the "Prior Plan") to, among other things, increase the number of shares of common stock available for issuance from 13.25 million to 16.75 million and make certain other amendments to the Prior Plan. Giving effect to this increase, there were 3.1 million additional shares remaining available for grant under the Plans at December 31, 2019.
The table below summarizes the expense recognized within general and administrative expenses in the Consolidated Statements of Income related to share-based payments recognized for the years ended December 31 (in thousands):
 
 
 
2019
 
2018
 
2017
Stock options
 
$
32,736

 
$
43,443

 
$
56,400

Restricted stock
 
28,217

 
26,496

 
36,897

Stock-based compensation
 
$
60,953

 
$
69,939

 
$
93,297


The tax benefits recorded on stock based compensation expense and upon the exercises of options were $61.6 million, $37.3 million and $48.6 million for the years ended December 31, 2019, 2018 and 2017, respectively.
The following table summarizes the Company’s total unrecognized compensation cost related to stock-based compensation as of December 31, 2019 (cost in thousands):
 
 
 
Unrecognized
Compensation
Cost
 
Weighted Average
Period of Expense
Recognition
(in Years)
Stock options
 
$
37,349

 
1.15
Restricted stock
 
36,936

 
1.44
Total
 
$
74,285

 
 


Stock Options
The following summarizes the changes in the number of shares of common stock under option for the following periods (shares and aggregate intrinsic value in thousands): 
 
 
Shares
 
Weighted
Average
Exercise
Price
 
Options
Exercisable
at End of
Year
 
Weighted
Average
Exercise
Price of
Exercisable
Options
 
Weighted
Average Fair
Value of
Options
Granted During
the Year
 
Aggregate
Intrinsic
Value
Outstanding at December 31, 2016
 
6,146

 
$
91.20

 
3,429

 
$
55.00

 
 
 
$
309,238

Granted
 
2,885

 
145.35

 
 
 
 
 
$
32.57

 
 
Exercised
 
(633
)
 
71.43

 
 
 
 
 
 
 
76,546

Forfeited
 
(367
)
 
144.51

 
 
 
 
 
 
 
 
Outstanding at December 31, 2017
 
8,031

 
109.78

 
4,029

 
75.80

 
 
 
663,815

Granted
 
412

 
204.59

 
 
 
 
 
$
50.07

 
 
Exercised
 
(708
)
 
73.26

 
 
 
 
 
 
 
79,588

Forfeited
 
(119
)
 
155.41

 
 
 
 
 
 
 
 
Outstanding at December 31, 2018
 
7,616

 
117.58

 
5,174

 
98.39

 
 
 
518,954

Granted
 
431

 
244.35

 
 
 
 
 
$
57.99

 
 
Exercised
 
(1,482
)
 
115.53

 
 
 
 
 
 
 
255,242

Forfeited
 
(302
)
 
167.35

 
 
 
 
 
 
 
 
Outstanding at December 31, 2019
 
6,263

 
$
124.38

 
5,137

 
$
109.03

 
 
 
$
1,022,860

Expected to vest at December 31, 2019
 
1,126

 
$
194.44

 
 
 
 
 
 
 
 


The following table summarizes information about stock options outstanding at December 31, 2019 (shares in thousands): 
Exercise Price
 
Options
Outstanding
 
Weighted Average
Remaining Vesting
Life in Years
 
Options
Exercisable
$10.00 – $114.90
 
2,242

 
0.00
 
2,242

121.76 – 150.74
 
2,834

 
0.21
 
2,516

151.16 – 165.96
 
352

 
0.61
 
227

172.68 – 199.75
 
342

 
1.29
 
124

202.02 – 209.05
 
69

 
2.28
 
7

216.18 – 231.70
 
144

 
2.82
 
21

252.50 – 288.37
 
280

 
2.88
 

 
 
6,263

 
 
 
5,137


The aggregate intrinsic value of stock options exercisable at December 31, 2019 was $917.9 million. The weighted average remaining contractual term of options exercisable at December 31, 2019 was 4.9 years.
The fair value of stock option awards granted was estimated using the Black-Scholes option pricing model with the following weighted-average assumptions for grants or modifications during the years ended December 31 as follows:
 


2019
 
2018
 
2017
Risk-free interest rate

2.40
%
 
2.57
%
 
1.65
%
Dividend yield


 

 

Expected volatility

26.40
%
 
26.92
%
 
28.00
%
Expected life (in years)

3.7

 
3.8

 
3.4


The weighted-average remaining contractual life for options outstanding was 5.4 years at December 31, 2019.
Restricted Stock

The fair value of restricted stock units granted with market based vesting conditions was estimated using the Monte Carlo simulation valuation model with the following assumptions during 2019. There were no restricted stock shares granted with market based vesting conditions in 2018 and 2017.

 
 
2019
Risk-free interest rate
 
1.48
%
Dividend yield
 

Expected volatility
 
25.40
%
Expected life (in years)
 
2.36



The following table summarizes the changes in the number of shares of restricted stock and restricted stock units for the following periods (shares in thousands): 
 
 
Shares
 
Weighted
Average
Grant Date
Fair Value
Outstanding at December 31, 2016
 
379

 
$
140.39

Granted
 
238

 
141.99

Cancelled
 
(48
)
 
152.95

Issued
 
(204
)
 
136.85

Outstanding at December 31, 2017
 
365

 
155.58

Granted
 
107

 
200.71

Cancelled
 
(47
)
 
339.34

Issued
 
(251
)
 
154.85

Outstanding at December 31, 2018
 
174

 
190.73

Granted
 
232

 
212.79

Cancelled
 
(49
)
 
225.96

Issued
 
(114
)
 
206.05

Outstanding at December 31, 2019
 
243

 
$
246.34